Jennifer E Miller

Jennifer E Miller is an Associate Professor of Medicine (General Internal Medicine) and Biomedical Informatics & Data Science at Yale School of Medicine. She serves as Co-Director of the Program for Biomedical Ethics and holds leadership positions including Director of the Good Pharma Scorecard (an index that ranks pharmaceutical companies on bioethical performance) and Founder of Bioethics International. Her academic appointments reflect her interdisciplinary expertise spanning clinical medicine, ethics, and data science.

Dr. Miller's research program focuses on critical ethical dimensions of biomedical innovation, with particular emphasis on ethics, equity and governance in drug, vaccine, and medical device research, development, and accessibility. She specializes in developing metrics to enhance accountability and social responsibility in the pharmaceutical industry. Her work examines clinical trial diversity, international research ethics, healthcare data sharing, and the implementation of ethical frameworks in medical product development. Through the Good Pharma Scorecard initiative, she has created a systematic approach to evaluating pharmaceutical company performance across multiple ethical dimensions including clinical trial transparency, diversity in research participation, and access to medicines.

Analysis of Dr. Miller's recent publications (2021-2025) reveals a strong thematic focus on diversity and equity in clinical research, with particular attention to demographic representation in trials, ethical considerations in international trial site selection, and equitable access to newly approved drugs and vaccines. Her work bridges bioethics, health policy, and data science, creating measurable frameworks for assessing ethical performance in the pharmaceutical industry. The interdisciplinary nature of her research connects clinical medicine, public health, and corporate accountability, with direct implications for regulatory policy and industry practice.

• Appointment to World Economic Forum Center for the Fourth Industrial Revolution, Precision Medicine Council (2019)
• Appointment to World Economic Forum Biotechnology Council (2018)
• Appointment to World Economic Forum Futures Council (2017)
• Appointment to World Economic Forum Human Enhancement Working Group (2017)
• Fellow at Foundation Brocher for Ethical Issues in Global Population Health (2014)

As Director of the Good Pharma Scorecard and Founder of Bioethics International, Dr. Miller leads initiatives that connect academic research with practical applications in industry ethics. Her work involves collaboration with pharmaceutical companies, regulatory agencies, and patient advocacy groups to develop and implement ethical standards in biomedical innovation. Through editorial roles at journals including Nature Medicine, The BMJ, and JAMA, she influences discourse on research ethics and scientific integrity. Dr. Miller is actively involved in advising and mentorship through her academic appointments at Yale, where she contributes to training the next generation of researchers in biomedical ethics and data science.